このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

REsistance and LOADing Exercise for Bone Health (RELOAD)

2026年9月11日 更新者:Marina De Vecchis、Defence Medical Rehabilitation Centre, UK

The Feasibility and Safety of a Resistance and High-impact Home Exercise Program to Improve Bone Mineral Density in Individuals With Post-traumatic, Unilateral Transtibial Limb Loss

Lower limb amputation, often resulting from military conflict and road traffic accidents, is associated with reduced hip bone mineral density (BMD) and increased risk of hip fractures. This bone loss is attributed to altered mechanical loading and is compounded by an increased falls risk in prosthesis users. While resistance and high-impact exercise interventions have proven effective in enhancing BMD in other populations, no studies have examined their role in amputees. Building on an international Delphi consensus guidelines, this study aims to assess the feasibility and safety of a novel home-based, tele-supervised resistance and high-impact exercise intervention in individuals with unilateral transtibial limb loss.

A convenience sample of 10 male prosthesis wearers from the ongoing ADVANCE Study will be involved in the study for 10 weeks and will undertake an 8-week, twice-weekly exercise program including resistance (squat, deadlift, overhead press) and impact-based activities (e.g., multidirectional jumps) (week 2 to week 9 of the study participation). Remote supervision will be provided twice weekly during the first week of exercise and once weekly thereafter. The primary outcomes are feasibility (recruitment, retention, compliance, acceptability, tolerance) and safety (adverse event monitoring). Secondary outcomes include changes in hip muscle strength and neuromuscular performance, assessed at baseline (week 1 of the study participation) and post-intervention (week 10 of the study participation) using isokinetic dynamometry, and force plates, respectively.

This study will provide the first evidence on the feasibility and safety of a targeted exercise intervention to stabilise or improve BMD in unilateral transtibial amputees. Findings will inform the design of a subsequent randomised controlled trial to evaluate efficacy, with potential to shape clinical rehabilitation programmes for military and civilian amputee populations at risk of low BMD and related complications.

調査の概要

研究の種類

介入

入学 (推定)

10

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

      • Loughborough、イギリス
        • 募集
        • Defence Medical Rehabilitation Centre, Stanford Hall
        • コンタクト:
          • Marina De Vecchis

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Current or previous British Armed Forces Personnel who are members of the ADVANCE Study (Bennett et al., 2020)
  • Male
  • Aged ≥ 18 years and ≤ 55 years
  • History of unilateral below knee limb loss due to trauma
  • Ambulating with their current prosthetic limb for a minimum of six months
  • Full-time prosthesis wearer (i.e., wearing the prosthesis every day, for most of the day, removing it mainly for sleeping or when resting for extended periods)
  • Able to walk independently using a prosthetic limb
  • Able to perform jumping activities on the prosthetic limb
  • Able to communicate in English
  • Access to the internet and a computer/smartphone
  • Able to drive/be driven to and from the testing location for the purpose of transporting the exercise equipment provided by the research team

Exclusion Criteria:

  • Additional limb loss of the upper and/or lower limb other than the transtibial limb loss
  • Cardiovascular disease, diabetes, neurological injury
  • Sickle cell disease
  • Neurodegenerative disease
  • Limb loss as a result of a vascular condition
  • Orthopaedic or neurological issues in the intact/non-amputated limb
  • Additional neuromusculoskeletal pathology which may affect walking
  • Pain, irritation, swelling, or skin complaints in the residual limb which inhibit prosthetic use
  • Diseases affecting bone metabolism (other than osteoporosis/osteopenia; for example, osteomalacia, Paget's disease, hyper/hypoparathyroidism, osteogenesis imperfecta)
  • Traumatic head injury resulting in cognitive disability
  • Lack of capacity to give consent
  • Any contraindications to exercise and/or resistance training
  • Continuous immobilisation for seven days or more in the month prior to attendance
  • Use of assistive walking device when utilising the, other than a prosthetic limb
  • Unable to regularly attend the supervised training program

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:他の
  • 割り当て:なし
  • 介入モデル:単一グループの割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Exercise Intervention
Participants will complete an eight-week home-based resistance and high-impact weight-bearing exercise program twice a week, with tele-supervision.
Each exercise session consists of three resistance training exercises (dumbbell squat, dumbbell deadlift, dumbbell overhead press; for each exercise, 3 sets of 8-12 reps, at 70% of the participant's predicted one repetition maximum) and three impact exercises (vertical, forward, lateral jumps; 2 sets of 10 repetitions each and 2-3 minutes rest between sets).

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Adverse events (i.e., safety of the intervention)
時間枠:Through study completion, an average of 10 weeks
The number, seriousness, and severity of adverse events reported during the exercise program.
Through study completion, an average of 10 weeks
Recruitment and retention rates
時間枠:Through study completion, an average of 1 year
Recruitment rate (percentage of enrolled participants out of eligible participants) and retention rates (percentage of enrolled participants who complete the exercise programme to the end). Reasons for non-enrolment, and attrition (withdrawals or dropouts) will be noted systematically throughout the study.
Through study completion, an average of 1 year
Compliance
時間枠:Week 2 to week 9
Determined from individual training diaries. 100% compliance = completion of all exercise sessions
Week 2 to week 9
Acceptability
時間枠:Week 10
Measured via the Theoretical Framework of Acceptability questionnaire. This scale consists of 8 questions, 1 from each of the TFA constructs asked on a 5-point Likert scale for each question (1 = low acceptability; 5 = high acceptability), for a total composite acceptability score of 40.
Week 10
Tolerance
時間枠:Week 2 to week 9
After each exercise session, participants will be asked to complete a post-exercise questionnaire within the training diary containing the Borg Rate of Perceived Exertion, a scale from 6 to 20, where a higher number means more perceived exertion.
Week 2 to week 9

二次結果の測定

結果測定
メジャーの説明
時間枠
Neuromuscular performance
時間枠:Baseline (week 1) and follow-up (week 10)
This will be tested using a pair of portable force plates (1000 Hz recording frequency; Hawkin Dynamics, Portland, Maine, USA). Force outputs from an Isometric Mid-Thigh Pull (IMTP).
Baseline (week 1) and follow-up (week 10)
Hip muscles strength
時間枠:Baseline (week 1) and follow-up (week 10)
Hip strength. An IsoKinetic Dynamometer (IKD) (System 4, Biodex Medical Systems Inc., New York, USA) will be used for measuring the isometric peak torque of hip flexors, extensors, adductors and abductors (on both sides, tested in a random order).
Baseline (week 1) and follow-up (week 10)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年10月1日

一次修了 (推定)

2027年12月1日

研究の完了 (推定)

2027年12月1日

試験登録日

最初に提出

2026年9月8日

QC基準を満たした最初の提出物

2026年9月11日

最初の投稿 (実際)

2026年9月14日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月14日

QC基準を満たした最後の更新が送信されました

2026年9月11日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

追加の関連 MeSH 用語

その他の研究ID番号

  • 2469/MODREC/26

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する